3rd Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for AMGEN USA, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Support for biologics data exclusivity period in USMCA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER BATES | — |
Copyright/Patent/Trademark CPT
Issues related to pharmaceutical patents.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER BATES | — |
Health Issues HCR
Drug pricing issues, including the IPI Drug Pricing Model, Prescription Drug Pricing Act (S. 2543) and other congressional proposals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER BATES | — |
| BRENDAN DUNN New | Staff Mbr and Leg Asst to Sen Hatch Judiciary Comm and Sub-Comm, Apr04-May07, Aug07-May08; Special Counsel to Sen Hatch Fin Comm, Jan 11-Dec 12; Policy Adv and Counsel to Sen McConnell Majority Leader staff, Dec 12-May18. |
| LAUREN B O'BRIEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.